320: Jim Wilson's next venture, a surprise startup shutdown, & Lilly's Zepbound strategy
The Readout Loud
00:00
Lilly's Direct-to-Consumer Strategy
This chapter explores Lilly's strategic shift to a direct-to-consumer model for their medications in response to compounded drugs' popularity. It addresses the implications for consumer access, data collection concerns, and recent changes in drug pricing and couponing programs.
Transcript
Play full episode
